Artificial Tears: Clinical Trials

9 trials of Artificial Tears, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 terminated, 1 recruiting. 9 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Completed 5, Terminated 3, Recruiting 1
Phase 33Completed 2, Recruiting 1

Follow Artificial Tears: new trials by email Literature Review of Artificial Tears trials Research Report on Artificial Tears

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Surabgene Lomparvovec, Sham, Topical Steroid - Diabetic Retinopathy
Phase 2 / Phase 3RecruitingAbbVie5762026-06-012026-10-29
Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution
NCX 470, Placebo - Open Angle Glaucoma
Phase 2 / Phase 3CompletedNicox Ophthalmics, Inc.182023-12-122025-09-08
Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease
licaminlimab, vehicle of OCS-02, Artificial tears - Dry Eye Disease
Phase 2CompletedOculis1222023-11-292025-07-02
Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP)
SAF312 Placebo, SAF312 - Chronic Ocular Pain
Phase 2CompletedNovartis Pharmaceuticals1532021-04-212024-10-09
Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System
Artificial Tears - Thyroid Carcinoma, Radioactive Iodine Level
Phase 2TerminatedVanderbilt-Ingram Cancer Center92020-10-052024-01-18
Celecoxib for Thyroid Eye Disease
Celecoxib, artificial tears - Thyroid Eye Disease
Phase 2TerminatedJohns Hopkins University72017-03-052020-07-31
Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration
Dorzolamide-timolol, Artificial tears - Neovascular Age-related Macular Degeneration, Wet Macular Degeneration
Phase 2 / Phase 3CompletedWills Eye522017-02-082020-06-19
Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis
Ketotifen 4.0% Patch, Placebo, Olopatadine 0.2% - Allergic Conjunctivitis
Phase 2CompletedSenju USA, Inc.1222009-02-012023-08-04
Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
Euphrasia-based homeopathic therapy, Cyclosporin solution - Dry Eye Syndromes
Phase 2TerminatedUniversity of Missouri-Columbia72007-12-012017-01-12

Conditions studied

Dry Eye Syndromes (2)  ·  Conjunctivitis, Allergic (1)  ·  Diabetic Retinopathy (1)  ·  Eye Pain (1)  ·  Glaucoma (1)  ·  Glaucoma, Open-Angle (1)  ·  Graves Ophthalmopathy (1)  ·  Lacrimal Apparatus Diseases (1)  ·  Macular Degeneration (1)  ·  Thyroid Neoplasms (1)  ·  Wet Macular Degeneration (1)

Sponsors

AbbVie (1)  ·  Johns Hopkins University (1)  ·  Nicox Ophthalmics, Inc. (1)  ·  Novartis Pharmaceuticals (1)  ·  Oculis (1)  ·  Senju USA, Inc. (1)  ·  University of Missouri-Columbia (1)  ·  Vanderbilt-Ingram Cancer Center (1)  ·  Wills Eye (1)

Countries

United States (9)  ·  Japan (1)  ·  Puerto Rico (1)  ·  United Kingdom (1)

Top investigators

Gail Torkildsen, MD (1)  ·  Jason Hsu, MD (1)  ·  Lenworth N Johnson, MD (1)  ·  Rachel Sobel, MD (1)  ·  Sharon Klier, MD, MPH (1)  ·  Timothy J McCulley, MD (1)

Results publications

PMID 32239190, PMID 36729473, PMID 37917111